β-Naphtoflavone and Ethanol Induce Cytochrome P450 and Protect towards MPP+ Toxicity in Human Neuroblastoma SH-SY5Y Cells
Cytochrome P450 (CYP) isozymes vary their expression depending on the brain area, the cell type, and the presence of drugs. Some isoforms are involved in detoxification and/or toxic activation of xenobiotics in central nervous system. However, their role in brain metabolism and neurodegeneration is...
Saved in:
| Published in | International journal of molecular sciences Vol. 19; no. 11; p. 3369 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
MDPI AG
28.10.2018
MDPI |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1422-0067 1661-6596 1422-0067 |
| DOI | 10.3390/ijms19113369 |
Cover
Loading…
| Abstract | Cytochrome P450 (CYP) isozymes vary their expression depending on the brain area, the cell type, and the presence of drugs. Some isoforms are involved in detoxification and/or toxic activation of xenobiotics in central nervous system. However, their role in brain metabolism and neurodegeneration is still a subject of debate. We have studied the inducibility of CYP isozymes in human neuroblastoma SH-SY5Y cells, treated with β-naphtoflavone (β-NF) or ethanol (EtOH) as inducers, by qRT-PCR, Western blot (WB), and metabolic activity assays. Immunohistochemistry was used to localize the isoforms in mitochondria and/or endoplasmic reticulum (ER). Tetrazolium (MTT) assay was performed to study the role of CYPs during methylphenyl pyridine (MPP+) exposure. EtOH increased mRNA and protein levels of CYP2D6 by 73% and 60% respectively. Both β-NF and EtOH increased CYP2E1 mRNA (4- and 1.4-fold, respectively) and protein levels (64% both). The 7-ethoxycoumarin O-deethylation and dextromethorphan O-demethylation was greater in treatment samples than in controls. Furthermore, both treatments increased by 22% and 18%, respectively, the cell viability in MPP+-treated cells. Finally, CYP2D6 localized at mitochondria and ER. These data indicate that CYP is inducible in SH-SY5Y cells and underline this in vitro system for studying the role of CYPs in neurodegeneration. |
|---|---|
| AbstractList | Cytochrome P450 (CYP) isozymes vary their expression depending on the brain area, the cell type, and the presence of drugs. Some isoforms are involved in detoxification and/or toxic activation of xenobiotics in central nervous system. However, their role in brain metabolism and neurodegeneration is still a subject of debate. We have studied the inducibility of CYP isozymes in human neuroblastoma SH-SY5Y cells, treated with β-naphtoflavone (β-NF) or ethanol (EtOH) as inducers, by qRT-PCR, Western blot (WB), and metabolic activity assays. Immunohistochemistry was used to localize the isoforms in mitochondria and/or endoplasmic reticulum (ER). Tetrazolium (MTT) assay was performed to study the role of CYPs during methylphenyl pyridine (MPP+) exposure. EtOH increased mRNA and protein levels of CYP2D6 by 73% and 60% respectively. Both β-NF and EtOH increased CYP2E1 mRNA (4- and 1.4-fold, respectively) and protein levels (64% both). The 7-ethoxycoumarin O-deethylation and dextromethorphan O-demethylation was greater in treatment samples than in controls. Furthermore, both treatments increased by 22% and 18%, respectively, the cell viability in MPP+-treated cells. Finally, CYP2D6 localized at mitochondria and ER. These data indicate that CYP is inducible in SH-SY5Y cells and underline this in vitro system for studying the role of CYPs in neurodegeneration. Cytochrome P450 (CYP) isozymes vary their expression depending on the brain area, the cell type, and the presence of drugs. Some isoforms are involved in detoxification and/or toxic activation of xenobiotics in central nervous system. However, their role in brain metabolism and neurodegeneration is still a subject of debate. We have studied the inducibility of CYP isozymes in human neuroblastoma SH-SY5Y cells, treated with β-naphtoflavone (β-NF) or ethanol (EtOH) as inducers, by qRT-PCR, Western blot (WB), and metabolic activity assays. Immunohistochemistry was used to localize the isoforms in mitochondria and/or endoplasmic reticulum (ER). Tetrazolium (MTT) assay was performed to study the role of CYPs during methylphenyl pyridine (MPP + ) exposure. EtOH increased mRNA and protein levels of CYP2D6 by 73% and 60% respectively. Both β-NF and EtOH increased CYP2E1 mRNA (4- and 1.4-fold, respectively) and protein levels (64% both). The 7-ethoxycoumarin O -deethylation and dextromethorphan O -demethylation was greater in treatment samples than in controls. Furthermore, both treatments increased by 22% and 18%, respectively, the cell viability in MPP + -treated cells. Finally, CYP2D6 localized at mitochondria and ER. These data indicate that CYP is inducible in SH-SY5Y cells and underline this in vitro system for studying the role of CYPs in neurodegeneration. Cytochrome P450 (CYP) isozymes vary their expression depending on the brain area, the cell type, and the presence of drugs. Some isoforms are involved in detoxification and/or toxic activation of xenobiotics in central nervous system. However, their role in brain metabolism and neurodegeneration is still a subject of debate. We have studied the inducibility of CYP isozymes in human neuroblastoma SH-SY5Y cells, treated with β-naphtoflavone (β-NF) or ethanol (EtOH) as inducers, by qRT-PCR, Western blot (WB), and metabolic activity assays. Immunohistochemistry was used to localize the isoforms in mitochondria and/or endoplasmic reticulum (ER). Tetrazolium (MTT) assay was performed to study the role of CYPs during methylphenyl pyridine (MPP⁺) exposure. EtOH increased mRNA and protein levels of CYP2D6 by 73% and 60% respectively. Both β-NF and EtOH increased CYP2E1 mRNA (4- and 1.4-fold, respectively) and protein levels (64% both). The 7-ethoxycoumarin O-deethylation and dextromethorphan O-demethylation was greater in treatment samples than in controls. Furthermore, both treatments increased by 22% and 18%, respectively, the cell viability in MPP⁺-treated cells. Finally, CYP2D6 localized at mitochondria and ER. These data indicate that CYP is inducible in SH-SY5Y cells and underline this in vitro system for studying the role of CYPs in neurodegeneration.Cytochrome P450 (CYP) isozymes vary their expression depending on the brain area, the cell type, and the presence of drugs. Some isoforms are involved in detoxification and/or toxic activation of xenobiotics in central nervous system. However, their role in brain metabolism and neurodegeneration is still a subject of debate. We have studied the inducibility of CYP isozymes in human neuroblastoma SH-SY5Y cells, treated with β-naphtoflavone (β-NF) or ethanol (EtOH) as inducers, by qRT-PCR, Western blot (WB), and metabolic activity assays. Immunohistochemistry was used to localize the isoforms in mitochondria and/or endoplasmic reticulum (ER). Tetrazolium (MTT) assay was performed to study the role of CYPs during methylphenyl pyridine (MPP⁺) exposure. EtOH increased mRNA and protein levels of CYP2D6 by 73% and 60% respectively. Both β-NF and EtOH increased CYP2E1 mRNA (4- and 1.4-fold, respectively) and protein levels (64% both). The 7-ethoxycoumarin O-deethylation and dextromethorphan O-demethylation was greater in treatment samples than in controls. Furthermore, both treatments increased by 22% and 18%, respectively, the cell viability in MPP⁺-treated cells. Finally, CYP2D6 localized at mitochondria and ER. These data indicate that CYP is inducible in SH-SY5Y cells and underline this in vitro system for studying the role of CYPs in neurodegeneration. Cytochrome P450 (CYP) isozymes vary their expression depending on the brain area, the cell type, and the presence of drugs. Some isoforms are involved in detoxification and/or toxic activation of xenobiotics in central nervous system. However, their role in brain metabolism and neurodegeneration is still a subject of debate. We have studied the inducibility of CYP isozymes in human neuroblastoma SH-SY5Y cells, treated with β-naphtoflavone (β-NF) or ethanol (EtOH) as inducers, by qRT-PCR, Western blot (WB), and metabolic activity assays. Immunohistochemistry was used to localize the isoforms in mitochondria and/or endoplasmic reticulum (ER). Tetrazolium (MTT) assay was performed to study the role of CYPs during methylphenyl pyridine (MPP⁺) exposure. EtOH increased mRNA and protein levels of CYP2D6 by 73% and 60% respectively. Both β-NF and EtOH increased CYP2E1 mRNA (4- and 1.4-fold, respectively) and protein levels (64% both). The 7-ethoxycoumarin -deethylation and dextromethorphan -demethylation was greater in treatment samples than in controls. Furthermore, both treatments increased by 22% and 18%, respectively, the cell viability in MPP⁺-treated cells. Finally, CYP2D6 localized at mitochondria and ER. These data indicate that CYP is inducible in SH-SY5Y cells and underline this in vitro system for studying the role of CYPs in neurodegeneration. |
| Author | Fernandez-Abascal, Jesus Leone, Cosima Ripullone, Mariantonia Valeri, Aurora Valoti, Massimo |
| AuthorAffiliation | 2 Molecular Horizon srl, Via Montelino 32, Bettona, 06084 Perugia, Italy; aurora.valeri@molhorizon.it 1 Dipartimento di Scienze della Vita, Università di Siena, Via Aldo Moro 2, 53100 Siena, Italy; mariantonia.ripullone@gmail.com (M.R.); leone27@student.unisi.it (C.L.); massimo.valoti@unisi.it (M.V.) |
| AuthorAffiliation_xml | – name: 2 Molecular Horizon srl, Via Montelino 32, Bettona, 06084 Perugia, Italy; aurora.valeri@molhorizon.it – name: 1 Dipartimento di Scienze della Vita, Università di Siena, Via Aldo Moro 2, 53100 Siena, Italy; mariantonia.ripullone@gmail.com (M.R.); leone27@student.unisi.it (C.L.); massimo.valoti@unisi.it (M.V.) |
| Author_xml | – sequence: 1 givenname: Jesus orcidid: 0000-0002-9558-8331 surname: Fernandez-Abascal fullname: Fernandez-Abascal, Jesus – sequence: 2 givenname: Mariantonia surname: Ripullone fullname: Ripullone, Mariantonia – sequence: 3 givenname: Aurora orcidid: 0000-0003-4027-7613 surname: Valeri fullname: Valeri, Aurora – sequence: 4 givenname: Cosima surname: Leone fullname: Leone, Cosima – sequence: 5 givenname: Massimo orcidid: 0000-0002-7240-3576 surname: Valoti fullname: Valoti, Massimo |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30373287$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkUtrFEEUhQuJmIfuXEuBG0Fb69H16I0gQ3QCMQ4kLrIq7lRXOzV0V41V1dHxZ_lD_E12TAxjcHUv3O8ezuEcor0Qg0PoKSWvOW_IG78eMm0o5Vw2D9ABrRmrCJFqb2ffR4c5rwlhnInmEdrnhCvOtDpAP379rM5gsyqx6-FqUsYQWnxcVhBij09CO1qHZ9sS7SrFweFFLcgfZJFicbbgEr9BajP-uFi8xBfxu7e-bLEPeD4OEPCZG1Nc9pBLHACfz6vzS3GJZ67v82P0sIM-uye38wh9fn98MZtXp58-nMzenVa2pqxUUlthhQMuBOhGWyWZk4SRrtW15ZTUnRIcllA3HGpphbK8tUx1mlmr-FLyI_T2RnczLgfXWhdKgt5skh8gbU0Eb_69BL8yX-KVkUzVsqGTwItbgRS_ji4XM_hspwgQXByzYZQp2mgixIQ-v4eu45jCFM8woZnmkgk1Uc92Hd1Z-VvLBLy6AWyKOSfX3SGUmOvWzW7rE87u4VMJUHy8zuP7_z_9BlKisKM |
| CitedBy_id | crossref_primary_10_1186_s12964_020_00616_8 crossref_primary_10_3390_ijms25137439 crossref_primary_10_1289_EHP6993 crossref_primary_10_1038_s41598_024_84362_8 crossref_primary_10_1021_acs_est_4c06017 crossref_primary_10_3390_ijms21113955 crossref_primary_10_1016_j_dmd_2025_100068 crossref_primary_10_1016_j_neuro_2021_08_004 crossref_primary_10_1016_j_arabjc_2024_105657 crossref_primary_10_12677_PI_2023_122009 crossref_primary_10_1016_j_bej_2020_107860 crossref_primary_10_3389_fphar_2021_650027 crossref_primary_10_1038_s41598_019_48213_1 crossref_primary_10_1016_j_chemosphere_2021_132784 crossref_primary_10_1186_s12920_022_01400_y crossref_primary_10_3390_jox15020044 crossref_primary_10_1080_03602532_2020_1858856 |
| Cites_doi | 10.1038/npp.2008.110 10.1007/BF03033178 10.1124/dmd.113.051359 10.1038/sj.clpt.6100358 10.1111/j.1742-7843.2007.00121.x 10.1016/j.toxlet.2010.06.023 10.1093/toxsci/kfs150 10.1177/0891988714522698 10.1016/j.lfs.2006.11.022 10.1016/S0166-2236(00)01789-6 10.1016/j.tiv.2014.05.014 10.1016/0304-3940(91)90804-3 10.1016/j.ymgme.2009.08.009 10.1111/j.1742-4658.2011.08356.x 10.1124/dmd.112.046979 10.1016/S0014-2999(00)00078-9 10.1074/jbc.270.50.29632 10.1016/j.toxlet.2017.02.012 10.1503/jpn.120133 10.1517/17425255.2010.510832 10.1074/jbc.M212482200 10.1139/bcb-2014-0088 10.1006/meth.2001.1262 10.1124/dmd.109.027011 10.1016/j.abb.2017.03.009 10.1002/syn.20505 10.1016/j.neuropharm.2009.03.003 10.1016/j.neuropharm.2005.10.003 10.1074/jbc.M112.402123 10.1016/j.jns.2013.10.030 10.3109/00498254.2015.1040102 10.1016/j.tox.2017.04.001 10.1016/j.tox.2009.09.010 10.1016/j.neuro.2008.11.001 10.1074/jbc.M004431200 10.1124/dmd.115.063594 10.1111/j.1460-9568.2010.07142.x 10.4155/fmc.10.229 10.1371/journal.pone.0150587 10.1007/978-1-61779-012-6_9 10.1007/s10048-011-0308-3 10.1038/sj.bjp.0705146 10.1021/acschemneuro.6b00377 10.1124/jpet.103.054866 10.1097/00019052-199912000-00012 10.1007/s00204-014-1394-4 10.1016/j.gene.2013.11.097 10.1080/004982500406390 10.1007/s12035-016-9938-7 10.1046/j.1471-4159.2003.01927.x 10.1080/0049825021000048827 10.1016/j.neuropharm.2008.07.017 10.1093/nar/29.9.e45 10.1097/FPC.0000000000000231 10.1111/j.1528-1167.2010.02956.x 10.3109/03602532.2015.1101131 10.1186/1471-2105-7-85 10.1517/17425255.2010.503955 10.3109/00498254.2013.791410 10.1016/S1532-0456(01)00231-9 10.1016/j.parkreldis.2008.04.014 10.1371/journal.pone.0091946 10.1146/annurev-pharmtox-011613-135937 10.1016/j.neuroscience.2018.03.009 10.1074/jbc.M113.452367 10.1016/j.tips.2011.08.005 10.1016/j.toxlet.2014.09.005 10.1016/j.pharmthera.2012.12.007 10.1016/j.envpol.2017.04.015 10.1517/17425255.2013.759208 10.1006/bbrc.1998.9232 10.3390/ijms18030551 10.1186/s13024-017-0149-0 10.1111/ene.13353 10.2131/jts.41.775 10.1038/clpt.2012.186 10.1111/epi.12923 10.3109/15376516.2015.1070227 10.3389/fnbeh.2013.00071 10.1254/jphs.14132FP 10.3389/fnins.2016.00375 10.1089/dna.1997.16.725 10.1016/j.neuropharm.2014.05.018 10.3389/fnins.2018.00369 |
| ContentType | Journal Article |
| Copyright | 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2018 by the authors. 2018 |
| Copyright_xml | – notice: 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2018 by the authors. 2018 |
| DBID | AAYXX CITATION NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.3390/ijms19113369 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1422-0067 |
| ExternalDocumentID | PMC6274691 30373287 10_3390_ijms19113369 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: FP7 People: Marie-Curie Actions grantid: 608381 |
| GroupedDBID | --- 29J 2WC 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ 8G5 A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AFKRA AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 DWQXO E3Z EBD EBS EJD ESX F5P FRP FYUFA GNUQQ GUQSH GX1 HH5 HMCUK HYE IAO IHR IPNFZ ITC KQ8 LK8 M1P M2O M48 MODMG O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RIG RNS RPM TR2 TUS UKHRP ~8M NPM PJZUB PPXIY 3V. 7XB 8FK K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-c412t-68c5c5ea355a898c762e6020fd84c3104f753aba493a46c57c3dc27f82cc73b63 |
| IEDL.DBID | M48 |
| ISSN | 1422-0067 1661-6596 |
| IngestDate | Thu Aug 21 14:12:03 EDT 2025 Fri Jul 11 05:02:42 EDT 2025 Fri Jul 25 20:32:17 EDT 2025 Mon Jul 21 05:58:32 EDT 2025 Thu Apr 24 23:07:34 EDT 2025 Tue Jul 01 01:45:24 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | mitochondrial localization cytochrome P450 enzyme system xenobiotic toxicity cytochrome P450 induction Parkinson’s disease neurodegeneration and neuroprotection |
| Language | English |
| License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c412t-68c5c5ea355a898c762e6020fd84c3104f753aba493a46c57c3dc27f82cc73b63 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Present address: Department of Physiology and Biophysics, University of Miami, Miller School of Medicine, 1600 NW 10th Ave, Miami, FL 33136, USA. |
| ORCID | 0000-0002-7240-3576 0000-0002-9558-8331 0000-0003-4027-7613 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ijms19113369 |
| PMID | 30373287 |
| PQID | 2582836257 |
| PQPubID | 2032341 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6274691 proquest_miscellaneous_2127198055 proquest_journals_2582836257 pubmed_primary_30373287 crossref_primary_10_3390_ijms19113369 crossref_citationtrail_10_3390_ijms19113369 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20181028 |
| PublicationDateYYYYMMDD | 2018-10-28 |
| PublicationDate_xml | – month: 10 year: 2018 text: 20181028 day: 28 |
| PublicationDecade | 2010 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland – name: Basel |
| PublicationTitle | International journal of molecular sciences |
| PublicationTitleAlternate | Int J Mol Sci |
| PublicationYear | 2018 |
| Publisher | MDPI AG MDPI |
| Publisher_xml | – name: MDPI AG – name: MDPI |
| References | Livak (ref_92) 2001; 25 Dragoni (ref_48) 2003; 33 ref_13 Vaglini (ref_50) 2013; 7 ref_97 Sylvester (ref_96) 2011; 716 ref_15 Ravindranath (ref_18) 2013; 9 Binda (ref_95) 2017; 8 Pardini (ref_52) 2008; 14 Bertilsson (ref_43) 2007; 82 Ma (ref_88) 2018; 12 Sridar (ref_23) 2012; 40 Miksys (ref_87) 2013; 38 Yue (ref_42) 2008; 33 Feldman (ref_14) 1999; 12 ref_20 Yu (ref_63) 2001; 29 Dragoni (ref_94) 2012; 128 Shimada (ref_77) 1999; 27 Jenner (ref_17) 2001; 24 Boopathi (ref_16) 2000; 275 Pfaffl (ref_93) 2001; 29 ref_71 Imran (ref_64) 2015; 25 Singh (ref_72) 2014; 27 He (ref_45) 2015; 47 Roberts (ref_67) 1995; 270 Deng (ref_31) 2014; 126 Toselli (ref_28) 2015; 45 Pretti (ref_60) 2001; 130 Lee (ref_22) 2006; 50 Gambaro (ref_9) 2016; 90 Lamba (ref_19) 2003; 307 Wang (ref_25) 2003; 278 Nannelli (ref_29) 2009; 265 Dutheil (ref_2) 2009; 37 Na (ref_51) 2017; 385 Ramsay (ref_73) 2016; 10 Marini (ref_78) 2007; 80 Valoti (ref_49) 2000; 391 Goldman (ref_12) 2014; 54 Guevara (ref_53) 2017; 2017 Toselli (ref_83) 2013; 41 Zhu (ref_24) 2012; 92 Miksys (ref_79) 2002; 27 Ghosh (ref_33) 2015; 56 Dutheil (ref_7) 2010; 6 ref_58 Hellum (ref_65) 2007; 101 Sangar (ref_82) 2010; 6 Moran (ref_85) 2014; 28 Bansal (ref_5) 2013; 288 Vaglini (ref_54) 2001; 16 McGehee (ref_69) 1997; 16 Schmid (ref_46) 2016; 26 Cheung (ref_90) 2009; 30 Presgraves (ref_91) 2004; 5 Waxman (ref_62) 2006; 320 Zhang (ref_66) 2018; 379 Bromek (ref_37) 2010; 626 Hao (ref_86) 2010; 198 Sangar (ref_81) 2010; 99 Shahabi (ref_11) 2008; 62 Mann (ref_35) 2010; 31 Yamaori (ref_84) 2017; 4 Bajpai (ref_80) 2013; 288 Abiko (ref_27) 2016; 41 Kaut (ref_76) 2012; 13 Niwa (ref_39) 2017; 620 Cheng (ref_44) 2013; 43 Miksys (ref_1) 2009; 34 Lavandera (ref_6) 2015; 93 Hiroi (ref_38) 1998; 249 Dragoni (ref_47) 2003; 86 Tripathi (ref_57) 2017; 54 Mann (ref_41) 2008; 55 Ledesma (ref_68) 2014; 85 Howard (ref_70) 2003; 138 Miksys (ref_8) 2000; 30 Cabanas (ref_3) 2016; 2016 Naselli (ref_55) 2014; 536 ref_32 Gay (ref_89) 2010; 2 Zanger (ref_30) 2013; 138 Viaggi (ref_75) 2009; 56 Lu (ref_40) 2014; 336 Brauze (ref_59) 2014; 231 Xicoy (ref_56) 2017; 12 Viaggi (ref_74) 2006; 70 Elshenawy (ref_26) 2017; 270 Ghosh (ref_34) 2011; 52 Ferguson (ref_21) 2011; 32 Avadhani (ref_4) 2011; 278 Shahi (ref_61) 1991; 127 Uehara (ref_36) 2015; 43 Riedl (ref_10) 1999; 80 22539612 - Toxicol Sci. 2012 Jul;128(1):186-97 10676756 - Curr Opin Neurol. 1999 Dec;12(6):725-31 23491640 - Drug Metab Dispos. 2013 Jun;41(6):1187-94 26930610 - PLoS One. 2016 Mar 01;11(3):e0150587 24211060 - J Neurol Sci. 2014 Jan 15;336(1-2):161-8 23149928 - Clin Pharmacol Ther. 2012 Dec;92(6):771-7 11328886 - Nucleic Acids Res. 2001 May 1;29(9):e45 25735838 - Drug Metab Dispos. 2015 May;43(5):735-42 10729359 - Eur J Pharmacol. 2000 Mar 17;391(3):199-206 24050700 - Annu Rev Pharmacol Toxicol. 2014;54:141-64 10410732 - Adv Neurol. 1999;80:271-86 19298832 - Neuropharmacology. 2009 Jun;56(8):1075-81 11602530 - Drug Metab Dispos. 2001 Nov;29(11):1514-20 28118852 - Mol Neurodegener. 2017 Jan 24;12(1):10 12711639 - Br J Pharmacol. 2003 Apr;138(7):1376-86 16719387 - Methods Mol Biol. 2006;320:153-6 23471973 - J Biol Chem. 2013 May 3;288(18):12627-44 28105425 - Biomed Res Int. 2016;2016:5341081 26095139 - Xenobiotica. 2015;45(12):1129-37 18687346 - Neuropharmacology. 2008 Dec;55(7):1147-55 16309716 - Neuropharmacology. 2006 Mar;50(4):441-50 21294720 - Epilepsia. 2011 Mar;52(3):562-71 9212166 - DNA Cell Biol. 1997 Jun;16(6):725-36 19359404 - Drug Metab Dispos. 2009 Jul;37(7):1528-38 12491573 - J Psychiatry Neurosci. 2002 Nov;27(6):406-15 16504059 - BMC Bioinformatics. 2006 Feb 22;7:85 19056420 - Neurotoxicology. 2009 Jan;30(1):127-35 24663500 - PLoS One. 2014 Mar 24;9(3):e91946 20843279 - Expert Opin Drug Metab Toxicol. 2010 Oct;6(10):1161-74 18197273 - J Psychiatry Neurosci. 2008 Jan;33(1):54-63 20629582 - Expert Opin Drug Metab Toxicol. 2010 Oct;6(10):1231-51 25218365 - Toxicol Lett. 2014 Nov 18;231(1):99-107 9731223 - Biochem Biophys Res Commun. 1998 Aug 28;249(3):838-43 27977122 - ACS Chem Neurosci. 2017 May 17;8(5):1026-1035 10923858 - Xenobiotica. 2000 Jun;30(6):547-64 24584466 - J Geriatr Psychiatry Neurol. 2014 Jun;27(2):119-27 23258538 - J Biol Chem. 2013 Feb 8;288(6):4436-51 12623760 - Xenobiotica. 2003 Feb;33(2):181-95 17898711 - Clin Pharmacol Ther. 2007 Nov;82(5):606-9 24863043 - Neuropharmacology. 2014 Oct;85:36-44 23330950 - Expert Opin Drug Metab Toxicol. 2013 May;9(5):551-8 24333271 - Gene. 2014 Feb 15;536(1):29-39 10534312 - Drug Metab Dispos. 1999 Nov;27(11):1274-80 20615459 - Toxicol Lett. 2010 Oct 5;198(2):225-31 24929095 - Toxicol In Vitro. 2014 Oct;28(7):1206-14 19818757 - Eur J Pharmacol. 2010 Jan 25;626(2-3):171-8 28189647 - Toxicol Lett. 2017 Mar 15;270:34-50 27853106 - J Toxicol Sci. 2016;41(6):775-781 21929726 - FEBS J. 2011 Nov;278(22):4218-29 21975165 - Trends Pharmacol Sci. 2011 Dec;32(12):708-14 28347660 - Arch Biochem Biophys. 2017 Apr 15;620:23-27 20345925 - Eur J Neurosci. 2010 Apr;31(7):1185-93 28385499 - Toxicology. 2017 Jun 15;385:18-27 27597816 - Front Neurosci. 2016 Aug 22;10:375 15111235 - Neurotox Res. 2004;5(8):579-98 28727213 - Eur J Neurol. 2017 Sep;24(9):1191-1195 17017526 - J Neural Transm Suppl. 2006;(70):173-6 22936314 - Drug Metab Dispos. 2012 Dec;40(12):2256-66 28163821 - Oxid Med Cell Longev. 2017;2017:4680732 12571232 - J Biol Chem. 2003 Apr 18;278(16):14146-52 29904339 - Front Neurosci. 2018 May 31;12:369 17161434 - Life Sci. 2007 Feb 13;80(10):910-7 17910620 - Basic Clin Pharmacol Toxicol. 2007 Nov;101(5):350-8 25656284 - Epilepsia. 2015 Mar;56(3):439-49 25386744 - Biochem Cell Biol. 2015 Feb;93(1):102-7 11846609 - Methods. 2001 Dec;25(4):402-8 11311359 - Trends Neurosci. 2001 May;24(5):245-7 10915793 - J Biol Chem. 2000 Nov 3;275(44):34415-23 27253829 - Pharmacogenet Genomics. 2016 Aug;26(8):397-401 26567990 - Toxicol Mech Methods. 2015;25(9):689-97 28413083 - Environ Pollut. 2017 Jul;226:435-443 8530344 - J Biol Chem. 1995 Dec 15;270(50):29632-5 29555426 - Neuroscience. 2018 May 21;379:115-125 18288650 - Synapse. 2008 May;62(5):379-88 23199531 - J Psychiatry Neurosci. 2013 May;38(3):152-63 18668033 - Neuropsychopharmacology. 2009 Feb;34(3):634-40 26574146 - Drug Metab Rev. 2015;47(4):470-519 21103389 - Future Med Chem. 2010 Sep;2(9):1451-68 23614566 - Xenobiotica. 2013 Nov;43(11):973-84 1881637 - Neurosci Lett. 1991 Jun 24;127(2):247-50 12911625 - J Neurochem. 2003 Sep;86(5):1174-80 25370011 - Arch Toxicol. 2016 Feb;90(2):279-90 21318905 - Methods Mol Biol. 2011;716:157-68 18583171 - Parkinsonism Relat Disord. 2008;14 Suppl 2:S119-23 28273839 - Int J Mol Sci. 2017 Mar 04;18(3) 14551287 - J Pharmacol Exp Ther. 2003 Dec;307(3):906-22 11996504 - Funct Neurol. 2001;16(4 Suppl):107-12 22238121 - Neurogenetics. 2012 Feb;13(1):87-91 23333322 - Pharmacol Ther. 2013 Apr;138(1):103-41 25341566 - J Pharmacol Sci. 2014;126(2):146-54 19786062 - Toxicology. 2009 Nov 30;265(3):69-79 23801948 - Front Behav Neurosci. 2013 Jun 21;7:71 27206429 - Mol Neurobiol. 2017 Jul;54(5):3633-3651 19781968 - Mol Genet Metab. 2010 Jan;99(1):90-7 11544149 - Comp Biochem Physiol C Toxicol Pharmacol. 2001 Sep;130(1):133-44 |
| References_xml | – volume: 34 start-page: 634 year: 2009 ident: ref_1 article-title: Brain drug-metabolizing cytochrome P450 enzymes are active in vivo, demonstrated by mechanism-based enzyme inhibition publication-title: Neuropsychopharmacology doi: 10.1038/npp.2008.110 – volume: 5 start-page: 579 year: 2004 ident: ref_91 article-title: Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists publication-title: Neurotox. Res. doi: 10.1007/BF03033178 – volume: 41 start-page: 1187 year: 2013 ident: ref_83 article-title: Differential expression of human cytochrome P450 enzymes from the CYP3A subfamily in the brains of alcoholic subjects and drug-free controls publication-title: Drug Metab. Dispos. Biol. Fate Chem. doi: 10.1124/dmd.113.051359 – volume: 82 start-page: 606 year: 2007 ident: ref_43 article-title: Metabolism of antidepressant and neuroleptic drugs by cytochrome p450s: Clinical and interethnic aspects publication-title: Clin. Pharmacol. Ther. doi: 10.1038/sj.clpt.6100358 – volume: 101 start-page: 350 year: 2007 ident: ref_65 article-title: The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol publication-title: Basic Clin. Pharmacol. Toxicol. doi: 10.1111/j.1742-7843.2007.00121.x – volume: 198 start-page: 225 year: 2010 ident: ref_86 article-title: Aquaporin-4 knockout enhances astrocyte toxicity induced by 1-methyl-4-phenylpyridinium ion and lipopolysaccharide via increasing the expression of cytochrome P4502E1 publication-title: Toxicol. Lett. doi: 10.1016/j.toxlet.2010.06.023 – volume: 128 start-page: 186 year: 2012 ident: ref_94 article-title: Gold nanoparticles uptake and cytotoxicity assessed on rat liver precision-cut slices publication-title: Toxicol. Sci. doi: 10.1093/toxsci/kfs150 – ident: ref_71 – volume: 27 start-page: 119 year: 2014 ident: ref_72 article-title: Polymorphism in Cytochrome P450 2D6, Glutathione S-Transferases Pi 1 Genes, and Organochlorine Pesticides in Alzheimer Disease: A Case-Control Study in North Indian Population publication-title: J. Geriatr. Psychiatry Neurol. doi: 10.1177/0891988714522698 – volume: 80 start-page: 910 year: 2007 ident: ref_78 article-title: Expression, microsomal and mitochondrial activities of cytochrome P450 enzymes in brain regions from control and phenobarbital-treated rabbits publication-title: Life Sci. doi: 10.1016/j.lfs.2006.11.022 – volume: 16 start-page: 107 year: 2001 ident: ref_54 article-title: Cytochrome p450 and Parkinsonism: Protective role of CYP2E1 publication-title: Funct. Neurol. – volume: 24 start-page: 245 year: 2001 ident: ref_17 article-title: Parkinson’s disease, pesticides and mitochondrial dysfunction publication-title: Trends Neurosci. doi: 10.1016/S0166-2236(00)01789-6 – volume: 28 start-page: 1206 year: 2014 ident: ref_85 article-title: CYP2E1 induction leads to oxidative stress and cytotoxicity in glutathione-depleted cerebellar granule neurons publication-title: Toxicol. In Vitro doi: 10.1016/j.tiv.2014.05.014 – volume: 127 start-page: 247 year: 1991 ident: ref_61 article-title: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: Partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by beta-naphthoflavone-pretreatment publication-title: Neurosci. Lett. doi: 10.1016/0304-3940(91)90804-3 – volume: 99 start-page: 90 year: 2010 ident: ref_81 article-title: Identification of genetic variants of human cytochrome P450 2D6 with impaired mitochondrial targeting publication-title: Mol. Genet. Metab. doi: 10.1016/j.ymgme.2009.08.009 – volume: 278 start-page: 4218 year: 2011 ident: ref_4 article-title: Bimodal targeting of cytochrome P450s to endoplasmic reticulum and mitochondria: The concept of chimeric signals publication-title: FEBS J. doi: 10.1111/j.1742-4658.2011.08356.x – volume: 33 start-page: 54 year: 2008 ident: ref_42 article-title: Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: An investigation of induction and time course publication-title: J. Psychiatry Neurosci. – volume: 27 start-page: 406 year: 2002 ident: ref_79 article-title: Drug-metabolizing cytochrome P450s in the brain publication-title: J. Psychiatry Neurosci. – volume: 40 start-page: 2256 year: 2012 ident: ref_23 article-title: Inhibition of bupropion metabolism by selegiline: Mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts publication-title: Drug Metab. Dispos. Biol. Fate Chem. doi: 10.1124/dmd.112.046979 – volume: 391 start-page: 199 year: 2000 ident: ref_49 article-title: Cytochrome P450-dependent N-dealkylation of l-deprenyl in C57BL mouse liver microsomes: Effects of in vivo pretreatment with ethanol, phenobarbital, beta-naphthoflavone and l-deprenyl publication-title: Eur. J. Pharmacol. doi: 10.1016/S0014-2999(00)00078-9 – volume: 270 start-page: 29632 year: 1995 ident: ref_67 article-title: Ethanol induces CYP2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of CYP2E1 publication-title: J. Biol. Chem. doi: 10.1074/jbc.270.50.29632 – volume: 270 start-page: 34 year: 2017 ident: ref_26 article-title: Down-regulation of cytochrome P450 1A1 by monomethylarsonous acid in human HepG2 cells publication-title: Toxicol. Lett. doi: 10.1016/j.toxlet.2017.02.012 – volume: 38 start-page: 152 year: 2013 ident: ref_87 article-title: Cytochrome P450-mediated drug metabolism in the brain publication-title: J. Psychiatry Neurosci. doi: 10.1503/jpn.120133 – volume: 6 start-page: 1161 year: 2010 ident: ref_7 article-title: ABC transporters and cytochromes P450 in the human central nervous system: Influence on brain pharmacokinetics and contribution to neurodegenerative disorders publication-title: Expert Opin. Drug Metab. Toxicol. doi: 10.1517/17425255.2010.510832 – volume: 278 start-page: 14146 year: 2003 ident: ref_25 article-title: A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression publication-title: J. Biol. Chem. doi: 10.1074/jbc.M212482200 – volume: 93 start-page: 102 year: 2015 ident: ref_6 article-title: Cytochrome P450 expression in mouse brain: Specific isoenzymes involved in Phase I metabolizing system of porphyrinogenic agents in both microsomes and mitochondria publication-title: Biochem. Cell Biol. doi: 10.1139/bcb-2014-0088 – volume: 25 start-page: 402 year: 2001 ident: ref_92 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt Method publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 37 start-page: 1528 year: 2009 ident: ref_2 article-title: Xenobiotic-metabolizing enzymes and transporters in the normal human brain: Regional and cellular mapping as a basis for putative roles in cerebral function publication-title: Drug Metab. Dispos. Biol. Fate Chem. doi: 10.1124/dmd.109.027011 – volume: 620 start-page: 23 year: 2017 ident: ref_39 article-title: Effect of genetic polymorphism on the inhibition of dopamine formation from p-tyramine catalyzed by brain cytochrome P450 2D6 publication-title: Arch. Biochem. Biophys. doi: 10.1016/j.abb.2017.03.009 – volume: 62 start-page: 379 year: 2008 ident: ref_11 article-title: Cytochrome P450 2E1 in the substantia nigra: Relevance for dopaminergic neurotransmission and free radical production publication-title: Synapse doi: 10.1002/syn.20505 – volume: 56 start-page: 1075 year: 2009 ident: ref_75 article-title: MPTP-induced model of Parkinson’s disease in cytochrome P450 2E1 knockout mice publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2009.03.003 – volume: 50 start-page: 441 year: 2006 ident: ref_22 article-title: CYP2B6 is expressed in African Green monkey brain and is induced by chronic nicotine treatment publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2005.10.003 – volume: 80 start-page: 271 year: 1999 ident: ref_10 article-title: P450 and heme oxygenase enzymes in the basal ganglia and their roles in Parkinson’s disease publication-title: Adv. Neurol. – volume: 288 start-page: 4436 year: 2013 ident: ref_80 article-title: Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by mitochondrion-targeted cytochrome P450 2D6: Implications in Parkinson disease publication-title: J. Biol. Chem. doi: 10.1074/jbc.M112.402123 – volume: 336 start-page: 161 year: 2014 ident: ref_40 article-title: CYP2D6 phenotypes and Parkinson’s disease risk: A meta-analysis publication-title: J. Neurol. Sci. doi: 10.1016/j.jns.2013.10.030 – volume: 45 start-page: 1129 year: 2015 ident: ref_28 article-title: Gene expression profiling of cytochromes P450, ABC transporters and their principal transcription factors in the amygdala and prefrontal cortex of alcoholics, smokers and drug-free controls by qRT-PCR publication-title: Xenobiotica doi: 10.3109/00498254.2015.1040102 – volume: 385 start-page: 18 year: 2017 ident: ref_51 article-title: The induction of cytochrome P450 2E1 by ethanol leads to the loss of synaptic proteins via PPARalpha down-regulation publication-title: Toxicology doi: 10.1016/j.tox.2017.04.001 – volume: 265 start-page: 69 year: 2009 ident: ref_29 article-title: Effect of β-naphthoflavone on AhR-regulated genes (CYP1A1, 1A2, 1B1, 2S1, Nrf2, and GST) and antioxidant enzymes in various brain regions of pig publication-title: Toxicology doi: 10.1016/j.tox.2009.09.010 – volume: 626 start-page: 171 year: 2010 ident: ref_37 article-title: The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study publication-title: Eur. J. Neurosci. – volume: 30 start-page: 127 year: 2009 ident: ref_90 article-title: Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research publication-title: Neurotoxicology doi: 10.1016/j.neuro.2008.11.001 – volume: 275 start-page: 34415 year: 2000 ident: ref_16 article-title: Accumulation of mitochondrial P450MT2, NH2-terminal truncated cytochrome P4501A1 in rat brain during chronic treatment with β-naphthoflavone. A role in the metabolism of neuroactive drugs publication-title: J. Biol. Chem. doi: 10.1074/jbc.M004431200 – volume: 43 start-page: 735 year: 2015 ident: ref_36 article-title: Activation and deactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by cytochrome P450 enzymes and flavin-containing monooxygenases in common marmosets (Callithrix jacchus) publication-title: Drug Metab. Dispos. Biol. Fate Chem. doi: 10.1124/dmd.115.063594 – volume: 31 start-page: 1185 year: 2010 ident: ref_35 article-title: Cytochrome P450 2D6 enzyme neuroprotects against 1-methyl-4-phenylpyridinium toxicity in SH-SY5Y neuronal cells publication-title: Eur. J. Neurosci. doi: 10.1111/j.1460-9568.2010.07142.x – volume: 2 start-page: 1451 year: 2010 ident: ref_89 article-title: Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by X-ray crystallography and NMR publication-title: Future Med. Chem. doi: 10.4155/fmc.10.229 – ident: ref_20 doi: 10.1371/journal.pone.0150587 – volume: 716 start-page: 157 year: 2011 ident: ref_96 article-title: Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability publication-title: Methods Mol. Biol. doi: 10.1007/978-1-61779-012-6_9 – volume: 13 start-page: 87 year: 2012 ident: ref_76 article-title: Genome-scale methylation analysis of Parkinson’s disease patients’ brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1 publication-title: Neurogenetics doi: 10.1007/s10048-011-0308-3 – volume: 138 start-page: 1376 year: 2003 ident: ref_70 article-title: Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics publication-title: Br. J. Pharmacol. doi: 10.1038/sj.bjp.0705146 – volume: 8 start-page: 1026 year: 2017 ident: ref_95 article-title: Comparative Analysis of the Neurochemical Profile and MAO Inhibition Properties of N-(Furan-2-ylmethyl)-N-methylprop-2-yn-1-amine publication-title: ACS Chem. Neurosci. doi: 10.1021/acschemneuro.6b00377 – volume: 307 start-page: 906 year: 2003 ident: ref_19 article-title: Hepatic CYP2B6 expression: Gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.103.054866 – volume: 12 start-page: 725 year: 1999 ident: ref_14 article-title: The pathogenesis of neurodegenerative disease: Neurotoxic mechanisms of action and genetics publication-title: Curr. Opin. Neurol. doi: 10.1097/00019052-199912000-00012 – volume: 90 start-page: 279 year: 2016 ident: ref_9 article-title: Role of brain cytochrome P450 mono-oxygenases in bilirubin oxidation-specific induction and activity publication-title: Arch. Toxicol. doi: 10.1007/s00204-014-1394-4 – volume: 27 start-page: 1274 year: 1999 ident: ref_77 article-title: Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes publication-title: Drug Metab. Dispos. Biol. Fate Chem. – volume: 536 start-page: 29 year: 2014 ident: ref_55 article-title: Role and importance of polymorphisms with respect to DNA methylation for the expression of CYP2E1 enzyme publication-title: Gene doi: 10.1016/j.gene.2013.11.097 – volume: 30 start-page: 547 year: 2000 ident: ref_8 article-title: Regional and cellular distribution of CYP2D subfamily members in rat brain publication-title: Xenobiotica doi: 10.1080/004982500406390 – volume: 54 start-page: 3633 year: 2017 ident: ref_57 article-title: Monocrotophos Induces the Expression of Xenobiotic Metabolizing Cytochrome P450s (CYP2C8 and CYP3A4) and Neurotoxicity in Human Brain Cells publication-title: Mol. Neurobiol. doi: 10.1007/s12035-016-9938-7 – volume: 86 start-page: 1174 year: 2003 ident: ref_47 article-title: Cytochrome P450-dependent metabolism of l-deprenyl in monkey (Cercopithecus aethiops) and C57BL/6 mouse brain microsomal preparations publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.2003.01927.x – volume: 33 start-page: 181 year: 2003 ident: ref_48 article-title: l-Deprenyl metabolism by the cytochrome P450 system in monkey (Cercopithecus aethiops) liver microsomes publication-title: Xenobiotica doi: 10.1080/0049825021000048827 – volume: 70 start-page: 173 year: 2006 ident: ref_74 article-title: Cytochrome P450 and Parkinson’s disease: Protective role of neuronal CYP 2E1 from MPTP toxicity publication-title: J. Neural Transm. Suppl. – volume: 55 start-page: 1147 year: 2008 ident: ref_41 article-title: Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2008.07.017 – volume: 29 start-page: e45 year: 2001 ident: ref_93 article-title: A new mathematical model for relative quantification in real-time RT-PCR publication-title: Nucleic Acids Res. doi: 10.1093/nar/29.9.e45 – volume: 26 start-page: 397 year: 2016 ident: ref_46 article-title: CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals publication-title: Pharmacogenet. Genom. doi: 10.1097/FPC.0000000000000231 – volume: 52 start-page: 562 year: 2011 ident: ref_34 article-title: Cellular localization and functional significance of CYP3A4 in the human epileptic brain publication-title: Epilepsia doi: 10.1111/j.1528-1167.2010.02956.x – volume: 47 start-page: 470 year: 2015 ident: ref_45 article-title: Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine publication-title: Drug Metab. Rev. doi: 10.3109/03602532.2015.1101131 – ident: ref_97 doi: 10.1186/1471-2105-7-85 – volume: 6 start-page: 1231 year: 2010 ident: ref_82 article-title: Bimodal targeting of microsomal cytochrome P450s to mitochondria: Implications in drug metabolism and toxicity publication-title: Expert Opin. Drug Metab. Toxicol. doi: 10.1517/17425255.2010.503955 – volume: 43 start-page: 973 year: 2013 ident: ref_44 article-title: Potential role of CYP2D6 in the central nervous system publication-title: Xenobiotica doi: 10.3109/00498254.2013.791410 – volume: 29 start-page: 1514 year: 2001 ident: ref_63 article-title: Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: Can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities? publication-title: Drug Metab. Dispos. Biol. Fate Chem. – volume: 130 start-page: 133 year: 2001 ident: ref_60 article-title: Effects of beta-naphthoflavone on the cytochrome P450 system, and phase II enzymes in gilthead seabream (Sparus aurata) publication-title: Comp. Biochem. Physiol. C Toxicol. Pharmacol. doi: 10.1016/S1532-0456(01)00231-9 – volume: 14 start-page: S119 year: 2008 ident: ref_52 article-title: Role of CYP2E1 in the mouse model of MPTP toxicity publication-title: Parkinsonism Relat. Disord. doi: 10.1016/j.parkreldis.2008.04.014 – ident: ref_58 doi: 10.1371/journal.pone.0091946 – volume: 54 start-page: 141 year: 2014 ident: ref_12 article-title: Environmental toxins and Parkinson’s disease publication-title: Annu. Rev. Pharmacol. Toxicol. doi: 10.1146/annurev-pharmtox-011613-135937 – volume: 2016 start-page: 5341081 year: 2016 ident: ref_3 article-title: Regulation of Human Cytochrome P4501A1 (hCYP1A1): A Plausible Target for Chemoprevention? publication-title: Biomed. Res. Int. – volume: 379 start-page: 115 year: 2018 ident: ref_66 article-title: The Involvement of PPARs in the Selective Regulation of Brain CYP2D by Growth Hormone publication-title: Neuroscience doi: 10.1016/j.neuroscience.2018.03.009 – volume: 288 start-page: 12627 year: 2013 ident: ref_5 article-title: Human cytochrome P450 2E1 mutations that alter mitochondrial targeting efficiency and susceptibility to ethanol-induced toxicity in cellular models publication-title: J. Biol. Chem. doi: 10.1074/jbc.M113.452367 – volume: 32 start-page: 708 year: 2011 ident: ref_21 article-title: Cytochrome P450 enzymes in the brain: Emerging evidence of biological significance publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2011.08.005 – volume: 231 start-page: 99 year: 2014 ident: ref_59 article-title: Diversified expression of aryl hydrocarbon receptor dependent genes in human laryngeal squamous cell carcinoma cell lines treated with β-naphthoflavone publication-title: Toxicol. Lett. doi: 10.1016/j.toxlet.2014.09.005 – volume: 138 start-page: 103 year: 2013 ident: ref_30 article-title: Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2012.12.007 – ident: ref_32 doi: 10.1016/j.envpol.2017.04.015 – volume: 9 start-page: 551 year: 2013 ident: ref_18 article-title: Cytochrome P450-mediated metabolism in brain: Functional roles and their implications publication-title: Expert Opin. Drug Metab. Toxicol. doi: 10.1517/17425255.2013.759208 – volume: 249 start-page: 838 year: 1998 ident: ref_38 article-title: Dopamine formation from tyramine by CYP2D6 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1998.9232 – ident: ref_15 doi: 10.3390/ijms18030551 – volume: 12 start-page: 10 year: 2017 ident: ref_56 article-title: The SH-SY5Y cell line in Parkinson’s disease research: A systematic review publication-title: Mol. Neurodegener. doi: 10.1186/s13024-017-0149-0 – ident: ref_13 doi: 10.1111/ene.13353 – volume: 2017 start-page: 4680732 year: 2017 ident: ref_53 article-title: The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain publication-title: Oxidat. Med. Cell. Longev. – volume: 41 start-page: 775 year: 2016 ident: ref_27 article-title: Quinone-mediated induction of cytochrome P450 1A1 in HepG2 cells through increased interaction of aryl hydrocarbon receptor with aryl hydrocarbon receptor nuclear translocator publication-title: J. Toxicol. Sci. doi: 10.2131/jts.41.775 – volume: 92 start-page: 771 year: 2012 ident: ref_24 article-title: CYP2B6 and bupropion’s smoking-cessation pharmacology: The role of hydroxybupropion publication-title: Clin. Pharmacol. Ther. doi: 10.1038/clpt.2012.186 – volume: 56 start-page: 439 year: 2015 ident: ref_33 article-title: Sertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: An in vitro study publication-title: Epilepsia doi: 10.1111/epi.12923 – volume: 25 start-page: 689 year: 2015 ident: ref_64 article-title: Different regulation of aryl hydrocarbon receptor-regulated genes in response to dioxin in undifferentiated and neuronally differentiated human neuroblastoma SH-SY5Y cells publication-title: Toxicol. Mech. Methods doi: 10.3109/15376516.2015.1070227 – volume: 7 start-page: 71 year: 2013 ident: ref_50 article-title: Acetaldehyde and Parkinsonism: Role of CYP450 2E1 publication-title: Front. Behav. Neurosci. doi: 10.3389/fnbeh.2013.00071 – volume: 126 start-page: 146 year: 2014 ident: ref_31 article-title: Resveratrol suppresses the inducible expression of CYP3A4 through the pregnane X receptor publication-title: J. Pharmacol. Sci. doi: 10.1254/jphs.14132FP – volume: 10 start-page: 375 year: 2016 ident: ref_73 article-title: Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration publication-title: Front. Neurosci. doi: 10.3389/fnins.2016.00375 – volume: 320 start-page: 153 year: 2006 ident: ref_62 article-title: Use of 7-ethoxycoumarin to monitor multiple enzymes in the human CYP1, CYP2, and CYP3 families publication-title: Methods Mol. Biol. – volume: 16 start-page: 725 year: 1997 ident: ref_69 article-title: Regulation of the hepatic CYP 2E1 gene during chronic alcohol exposure: Lack of an ethanol response element in the proximal 5′-flanking sequence publication-title: DNA Cell Biol. doi: 10.1089/dna.1997.16.725 – volume: 85 start-page: 36 year: 2014 ident: ref_68 article-title: Induction of brain cytochrome P450 2E1 boosts the locomotor-stimulating effects of ethanol in mice publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2014.05.018 – volume: 4 start-page: 6 year: 2017 ident: ref_84 article-title: Expression levels of 39 Cyp mRNAs in the mouse brain and neuroblastoma cell lines, C-1300N18 and NB2a—Strong expression of Cyp1b1 publication-title: Fund. Toxicol. Sci. – volume: 12 start-page: 369 year: 2018 ident: ref_88 article-title: Neuroprotective Effects of Proanthocyanidins, Natural Flavonoids Derived From Plants, on Rotenone-Induced Oxidative Stress and Apoptotic Cell Death in Human Neuroblastoma SH-SY5Y Cells publication-title: Front. Neurosci. doi: 10.3389/fnins.2018.00369 – reference: 10923858 - Xenobiotica. 2000 Jun;30(6):547-64 – reference: 26574146 - Drug Metab Rev. 2015;47(4):470-519 – reference: 23330950 - Expert Opin Drug Metab Toxicol. 2013 May;9(5):551-8 – reference: 1881637 - Neurosci Lett. 1991 Jun 24;127(2):247-50 – reference: 20629582 - Expert Opin Drug Metab Toxicol. 2010 Oct;6(10):1231-51 – reference: 18197273 - J Psychiatry Neurosci. 2008 Jan;33(1):54-63 – reference: 23199531 - J Psychiatry Neurosci. 2013 May;38(3):152-63 – reference: 24663500 - PLoS One. 2014 Mar 24;9(3):e91946 – reference: 25370011 - Arch Toxicol. 2016 Feb;90(2):279-90 – reference: 22936314 - Drug Metab Dispos. 2012 Dec;40(12):2256-66 – reference: 21318905 - Methods Mol Biol. 2011;716:157-68 – reference: 28273839 - Int J Mol Sci. 2017 Mar 04;18(3): – reference: 23471973 - J Biol Chem. 2013 May 3;288(18):12627-44 – reference: 28727213 - Eur J Neurol. 2017 Sep;24(9):1191-1195 – reference: 18668033 - Neuropsychopharmacology. 2009 Feb;34(3):634-40 – reference: 17161434 - Life Sci. 2007 Feb 13;80(10):910-7 – reference: 19359404 - Drug Metab Dispos. 2009 Jul;37(7):1528-38 – reference: 23333322 - Pharmacol Ther. 2013 Apr;138(1):103-41 – reference: 28385499 - Toxicology. 2017 Jun 15;385:18-27 – reference: 24050700 - Annu Rev Pharmacol Toxicol. 2014;54:141-64 – reference: 14551287 - J Pharmacol Exp Ther. 2003 Dec;307(3):906-22 – reference: 11996504 - Funct Neurol. 2001;16(4 Suppl):107-12 – reference: 28105425 - Biomed Res Int. 2016;2016:5341081 – reference: 17017526 - J Neural Transm Suppl. 2006;(70):173-6 – reference: 21929726 - FEBS J. 2011 Nov;278(22):4218-29 – reference: 19781968 - Mol Genet Metab. 2010 Jan;99(1):90-7 – reference: 23801948 - Front Behav Neurosci. 2013 Jun 21;7:71 – reference: 18687346 - Neuropharmacology. 2008 Dec;55(7):1147-55 – reference: 24211060 - J Neurol Sci. 2014 Jan 15;336(1-2):161-8 – reference: 28189647 - Toxicol Lett. 2017 Mar 15;270:34-50 – reference: 19056420 - Neurotoxicology. 2009 Jan;30(1):127-35 – reference: 10729359 - Eur J Pharmacol. 2000 Mar 17;391(3):199-206 – reference: 16309716 - Neuropharmacology. 2006 Mar;50(4):441-50 – reference: 19298832 - Neuropharmacology. 2009 Jun;56(8):1075-81 – reference: 20615459 - Toxicol Lett. 2010 Oct 5;198(2):225-31 – reference: 28163821 - Oxid Med Cell Longev. 2017;2017:4680732 – reference: 10534312 - Drug Metab Dispos. 1999 Nov;27(11):1274-80 – reference: 8530344 - J Biol Chem. 1995 Dec 15;270(50):29632-5 – reference: 11544149 - Comp Biochem Physiol C Toxicol Pharmacol. 2001 Sep;130(1):133-44 – reference: 19818757 - Eur J Pharmacol. 2010 Jan 25;626(2-3):171-8 – reference: 24584466 - J Geriatr Psychiatry Neurol. 2014 Jun;27(2):119-27 – reference: 27253829 - Pharmacogenet Genomics. 2016 Aug;26(8):397-401 – reference: 28347660 - Arch Biochem Biophys. 2017 Apr 15;620:23-27 – reference: 20843279 - Expert Opin Drug Metab Toxicol. 2010 Oct;6(10):1161-74 – reference: 26095139 - Xenobiotica. 2015;45(12):1129-37 – reference: 17898711 - Clin Pharmacol Ther. 2007 Nov;82(5):606-9 – reference: 26567990 - Toxicol Mech Methods. 2015;25(9):689-97 – reference: 17910620 - Basic Clin Pharmacol Toxicol. 2007 Nov;101(5):350-8 – reference: 15111235 - Neurotox Res. 2004;5(8):579-98 – reference: 27597816 - Front Neurosci. 2016 Aug 22;10:375 – reference: 23258538 - J Biol Chem. 2013 Feb 8;288(6):4436-51 – reference: 18288650 - Synapse. 2008 May;62(5):379-88 – reference: 21975165 - Trends Pharmacol Sci. 2011 Dec;32(12):708-14 – reference: 28413083 - Environ Pollut. 2017 Jul;226:435-443 – reference: 12491573 - J Psychiatry Neurosci. 2002 Nov;27(6):406-15 – reference: 16504059 - BMC Bioinformatics. 2006 Feb 22;7:85 – reference: 11602530 - Drug Metab Dispos. 2001 Nov;29(11):1514-20 – reference: 12711639 - Br J Pharmacol. 2003 Apr;138(7):1376-86 – reference: 25218365 - Toxicol Lett. 2014 Nov 18;231(1):99-107 – reference: 10915793 - J Biol Chem. 2000 Nov 3;275(44):34415-23 – reference: 24929095 - Toxicol In Vitro. 2014 Oct;28(7):1206-14 – reference: 19786062 - Toxicology. 2009 Nov 30;265(3):69-79 – reference: 9731223 - Biochem Biophys Res Commun. 1998 Aug 28;249(3):838-43 – reference: 16719387 - Methods Mol Biol. 2006;320:153-6 – reference: 28118852 - Mol Neurodegener. 2017 Jan 24;12(1):10 – reference: 11846609 - Methods. 2001 Dec;25(4):402-8 – reference: 24333271 - Gene. 2014 Feb 15;536(1):29-39 – reference: 21294720 - Epilepsia. 2011 Mar;52(3):562-71 – reference: 24863043 - Neuropharmacology. 2014 Oct;85:36-44 – reference: 20345925 - Eur J Neurosci. 2010 Apr;31(7):1185-93 – reference: 10410732 - Adv Neurol. 1999;80:271-86 – reference: 26930610 - PLoS One. 2016 Mar 01;11(3):e0150587 – reference: 22539612 - Toxicol Sci. 2012 Jul;128(1):186-97 – reference: 27853106 - J Toxicol Sci. 2016;41(6):775-781 – reference: 18583171 - Parkinsonism Relat Disord. 2008;14 Suppl 2:S119-23 – reference: 12571232 - J Biol Chem. 2003 Apr 18;278(16):14146-52 – reference: 27977122 - ACS Chem Neurosci. 2017 May 17;8(5):1026-1035 – reference: 23614566 - Xenobiotica. 2013 Nov;43(11):973-84 – reference: 21103389 - Future Med Chem. 2010 Sep;2(9):1451-68 – reference: 23149928 - Clin Pharmacol Ther. 2012 Dec;92(6):771-7 – reference: 9212166 - DNA Cell Biol. 1997 Jun;16(6):725-36 – reference: 11328886 - Nucleic Acids Res. 2001 May 1;29(9):e45 – reference: 10676756 - Curr Opin Neurol. 1999 Dec;12(6):725-31 – reference: 23491640 - Drug Metab Dispos. 2013 Jun;41(6):1187-94 – reference: 12911625 - J Neurochem. 2003 Sep;86(5):1174-80 – reference: 25386744 - Biochem Cell Biol. 2015 Feb;93(1):102-7 – reference: 29555426 - Neuroscience. 2018 May 21;379:115-125 – reference: 11311359 - Trends Neurosci. 2001 May;24(5):245-7 – reference: 25735838 - Drug Metab Dispos. 2015 May;43(5):735-42 – reference: 27206429 - Mol Neurobiol. 2017 Jul;54(5):3633-3651 – reference: 25656284 - Epilepsia. 2015 Mar;56(3):439-49 – reference: 25341566 - J Pharmacol Sci. 2014;126(2):146-54 – reference: 12623760 - Xenobiotica. 2003 Feb;33(2):181-95 – reference: 22238121 - Neurogenetics. 2012 Feb;13(1):87-91 – reference: 29904339 - Front Neurosci. 2018 May 31;12:369 |
| SSID | ssj0023259 |
| Score | 2.3262093 |
| Snippet | Cytochrome P450 (CYP) isozymes vary their expression depending on the brain area, the cell type, and the presence of drugs. Some isoforms are involved in... |
| SourceID | pubmedcentral proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 3369 |
| SubjectTerms | Brain Cytochrome Dopamine Drug interactions Ethanol Liver Metabolism Neuroblastoma Neurodegeneration Parkinson's disease Proteins Toxicity |
| SummonAdditionalLinks | – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3bbtQwELWgCIkXVO5bCjISPFVR14ntOE8VWnVZIVGt1FZqnyLfol2UJkuTIspn9UP6Tcw42bAFwbMnymVszznjyRlC3uN_eVkBJIc7ZTBbpSLD_DjyznBjpOOpC2qfR3J2yj-fibM-4db0ZZXrPTFs1K62mCPfj_F8B3ZbkR6svkXYNQpPV_sWGvfJAwaRBme4mn4aCFcSh2ZpDGJQJEUmu8L3BGj-_vLrRQNUBRgaljpvhqS_cOaf5ZIb8We6TR73wJF-7Dz9hNzz1VPysGslef2M_Ly9iY70atHWRam_15WnunL0EBPjdUmxQYf1dHLd1naBAgV0zsU4mMw7oQbahvrZhn6Zz_foSf1jaQGf02VFQ5qfBhEPA1C7rS80PZ5Fx-finE58WTbPyen08GQyi_q-CpHlLG4jqaywwmuAGlplysJ-6CXAxsIpbgHu8QI4jDaaZ4nm0orUJs7GaaFia9PEyOQF2argRV4RioSHyZg5DbGeaa3G0lmmkdYIbaUZkb31p81tLzqOvS_KHMgHOiLfdMSIfBisV53Yxj_sdtdeyvsl1-S_J8iIvBuGYbHgCYiufH0FNixOWabGQozIy86pw40glqNwEVyd3nH3YIBC3HdHquUiCHJj_yKZsZ3_P9Zr8gjQVhDTjdUu2Wovr_wbQDSteRum7S9vvvWx priority: 102 providerName: ProQuest |
| Title | β-Naphtoflavone and Ethanol Induce Cytochrome P450 and Protect towards MPP+ Toxicity in Human Neuroblastoma SH-SY5Y Cells |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30373287 https://www.proquest.com/docview/2582836257 https://www.proquest.com/docview/2127198055 https://pubmed.ncbi.nlm.nih.gov/PMC6274691 |
| Volume | 19 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3LbtNAFL3qQ6BuEM9iKNEgwQoZYmdeXiAEUUKE1MiijZSuopnxWAly7dK4qJHY8Ess-Qg-gi_hjh1bDaUbb-baln3Hc8-ZGZ8D8ML9lxelSHJoIrWbrZK-DmzXt4mmWvOEiqRS-xzz0YR-mrLpFjRuo-sXuPwvtXN-UpPz7PXl19U7_ODfOsaJlP3N4svpEmkHsi0ebcMu1iThTBwOabuegLCBRfW292tn7MFtHMadZo3YrE3XAOe_-yavFKLhXbizRpDkfZ3ye7Bl8_twq_aUXD2A779_-mN1Ni-LNFPfitwSlSdk4GbIi4w4pw5jSX9VFmbulApITFm3ColrxQZSVhtpl-Qwjv_8-EWOi8uFQahOFjmpZvxJpeehEXWXxakiRyP_6ISdkL7NsuVDmAwHx_2Rv7ZY8A0NwtLn0jDDrELUoWQkDQ6NliOCTBNJDSI_miKdUVrRqKcoN0yYXmJCkcrQGNHTvPcIdnJ8lMdAHPcJeBgkCst-oJTs8sQEyjEcpgzXHrxqXu7MrPXHnQ1GNkMe4rIyu5oVD1620We17sYNcQdNnmZN55mFbi0QKzMTHjxvm_G7cYshKrfFBcYEoQgi2WXMg_06re2Nmv7ggdhIeBvgNLk3W_LFvNLmdlZGPAqe3HjNp7CHmKuS1A3lAeyU5xf2GeKaUndgW0wFHuXwYwd2PwzG8eeOqzSsU3Xmv9Jp_Ig |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGEIIXxJ3CACOxpyla7MSO84AQKps6tlWV1kndU_AtalGXdEsGlB_FAz-E38Sx03QdCN72nJObj-3zffbxdxB6487lpTmQnNgI5VarRKCIDQNrVKwUN3FivNpnn_eO448jNlpDP9qzMC6tsp0T_URtSu3WyLep29-B2ZYl72Zngasa5XZX2xIaTbfYt_OvQNmqt3sfwL-blO7uDLu9YFFVINAxoXXAhWaaWQmBVopUaJgNLAfQlBsRawA7cQ4IXioZp5GMuWaJjoymSS6o1kmkeATPvYFuQuANXQphMrokeBH1xdkIxLyAs5Q3ifZRlIbbk8-nFVAjYIQutXo1BP6Fa_9Mz1yJd7v30N0FUMXvm551H63Z4gG61ZSunD9E33_9DPpyNq7LfCq_lIXFsjB4xy3El1PsCoJoi7vzutRjJ4iABzELvcmgEYbAtc_XrfDhYLCFh-W3iQY-gCcF9tsK2IuGKID2dXkq8VEvODphJ7hrp9PqETq-lhZ_jNYL-JGnCDuCRTglRgK2IFKKkBtNpKNRTGquOmirbdpML0TOXa2NaQZkxzkiW3VEB20urWeNuMc_7DZaL2WLIV5llx2yg14vL8PgdDsusrDlBdgQmpBUhIx10JPGqcsXAXZwQklwd3LF3UsDJ_x99UoxGXsBcFcviafk2f8_6xW63RseHmQHe_395-gOID0v5EvFBlqvzy_sC0BTtXrpuzBGn657zPwGoysyBw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYgL4lm2FDASPVVRE8d2nANCaNvVlsJqpbbS9hT8inZRmixNCiw_iyM_gt_EOI_tFgS3njN5jsfzffbkG4Reuf_y4hRIDjVCudUq4anA-p41iirFDY1MrfY54sMT-m7CJmvoZ_cvjCur7ObEeqI2hXZr5LvE7e_AbAsEPm3LIsZ7gzfzz57rIOV2Wrt2Gs0QObSLr0DfytcHe-DrbUIG-8f9odd2GPA0DUjlcaGZZlZC0pUiFhpmBssBQKVGUA3Ah6aA5qWSNA4l5ZpFOjSaRKkgWkeh4iFc9wa6GYWQNiGWoskl2QtJ3agtgPzncRbzpug-DGN_d_bprASaBOzQlVmvpsO_MO6fpZoruW9wD91tQSt-24yy-2jN5g_QraaN5eIh-v7rhzeS82lVpJn8UuQWy9zgfbcoX2TYNQfRFvcXVaGnThwBjynza5NxIxKBq7p2t8QfxuMdfFx8m2ngBniW43qLAdcCIgpgflWcSXw09I5O2Snu2ywrH6GTa_nij9F6Di_yBGFHtgJOAiMBZwRSCp8bHUhHqZjUXPXQTvdpE90Knru-G1kCxMc5Ill1RA9tL63njdDHP-y2Oi8lbbiXyeXg7KGXy8MQqG73Rea2uACbgERBLHzGemijceryRoAjnGgSnB1dcffSwImAXz2Sz6a1GLjrncTjYPP_j_UC3YZoSd4fjA6fojsA-mpNXyK20Hp1fmGfAbCq1PN6BGP08bpD5jfEBzY9 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%CE%B2-Naphtoflavone+and+Ethanol+Induce+Cytochrome+P450+and+Protect+towards+MPP%E2%81%BA+Toxicity+in+Human+Neuroblastoma+SH-SY5Y+Cells&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Fernandez-Abascal%2C+Jesus&rft.au=Ripullone%2C+Mariantonia&rft.au=Valeri%2C+Aurora&rft.au=Leone%2C+Cosima&rft.date=2018-10-28&rft.eissn=1422-0067&rft.volume=19&rft.issue=11&rft_id=info:doi/10.3390%2Fijms19113369&rft_id=info%3Apmid%2F30373287&rft.externalDocID=30373287 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon |